Evidence map›Paper›PMID 29219730›Full record

ArticleRNA biology2018

A comprehensive profile of circulating RNAs in human serum.

Sinan Uğur Umu, Hilde Langseth, Cecilie Bucher-Johannessen, Bastian Fromm, Andreas Keller, Eckart Meese, Marianne Lauritzen, Magnus Leithaug, Robert Lyle, Trine B Rounge

Open access · hybridAbstract read
In one paragraph

Article in RNA biology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 89 papers.

0numbers the graph read from it
0cells of the map it votes in
89citing papers in PubMed
5.4field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

89 citing papers in PubMed, 148 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Recommendations for Validating Omics Prediction Models: Insights from a Lung Cancer RNA Biomarker Study.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2025
    Article
  6. Differential Expression of Small Non-Coding RNAs in Uterine Leiomyomas.International journal of molecular sciences · 2025
    Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Review
  13. Article
  14. Article
  15. Review
  16. Review
  17. Liquid Biopsy: A Game Changer for Type 2 Diabetes.International journal of molecular sciences · 2024
    Review
  18. Article
  19. Article
  20. Review

29 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 2 countries.

Sinan Uğur Umua Department of Research , Cancer Registry of Norway , Oslo , Norway.ORCID 0000-0001-8081-7819
Hilde Langsetha Department of Research , Cancer Registry of Norway , Oslo , Norway.ORCID 0000-0002-9446-4855
Cecilie Bucher-Johannessena Department of Research , Cancer Registry of Norway , Oslo , Norway.ORCID 0000-0003-3277-269X
Bastian Frommb Department of Tumor Biology , Institute for Cancer Research, The Norwegian Radium Hospital, Oslo University Hospital , Nydalen, Oslo , Norway.ORCID 0000-0003-0352-3037
Andreas Kellerc Department of Clinical Bioinformatics , Saarland University , Saarbruecken , Germany.
Eckart Meesed Department of Human Genetics , Saarland University , Homburg/Saar , Germany.
Marianne Lauritzena Department of Research , Cancer Registry of Norway , Oslo , Norway.ORCID 0000-0002-0761-2558
Magnus Leithauge Department of Medical Genetics , Oslo University Hospital and University of Oslo , Oslo , Norway.ORCID 0000-0002-0271-0677
Robert Lylee Department of Medical Genetics , Oslo University Hospital and University of Oslo , Oslo , Norway.
Trine B Roungea Department of Research , Cancer Registry of Norway , Oslo , Norway.ORCID 0000-0003-2677-2722
Cancer Registry of Norway · NOOslo University Hospital · NOSaarland University · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Non-coding RNA (ncRNA) molecules have fundamental roles in cells and many are also stable in body fluids as extracellular RNAs. In this study, we used RNA sequencing (RNA-seq) to investigate the profile of small non-coding RNA (sncRNA) in human serum. We analyzed 10 billion Illumina reads from 477 serum samples, included in the Norwegian population-based Janus Serum Bank (JSB). We found that the core serum RNA repertoire includes 258 micro RNAs (miRNA), 441 piwi-interacting RNAs (piRNA), 411 transfer RNAs (tRNA), 24 small nucleolar RNAs (snoRNA), 125 small nuclear RNAs (snRNA) and 123 miscellaneous RNAs (misc-RNA). We also investigated biological and technical variation in expression, and the results suggest that many RNA molecules identified in serum contain signs of biological variation. They are therefore unlikely to be random degradation by-products. In addition, the presence of specific fragments of tRNA, snoRNA, Vault RNA and Y_RNA indicates protection from degradation. Our results suggest that many circulating RNAs in serum can be potential biomarkers.

Indexed as

BiomarkersCell-Free Nucleic AcidsGene Expression RegulationHigh-Throughput Nucleotide SequencingHumansMicroRNAsRNA, Small InterferingRNA, Small NucleolarRNA, Small UntranslatedRNA StabilityRNA, TransferSequence Analysis, RNABiomarkersCell-Free Nucleic AcidsMicroRNAsRNA, Small InterferingRNA, Small NucleolarRNA, Small UntranslatedRNA, TransferBioinformaticscancercirculating RNARNA fragmentsrna sequencingserumSmall RNA

Identifiers

PMID29219730
PMCPMC5798962
OpenAlexW2753580600

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.